Keith Faucher

Keith Faucher

Company: Aura Biosciences

Job title: Sr. Director Device Development & Innovation


Understanding the Evolving Extractables & Leachables (E&L) Regulatory Expectations to Circumvent Drug Product Approval Delays 12:00 pm

Highlighting potential drug-device interactions early on in development to reduce risk and achieve the best possible outcome Exploring E&L testing and analysis to quantify and assess risks associated with leachable impurities Reviewing regulatory requirements within Extractable & Leachable testing for combination productsRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.